A Case of Liver Metastasis of Gastrointestinal Stromal Tumor That Was Resected after Treatment with Imatinib Mesylate and Sunitinib
Korean Journal of Hepato-Biliary-Pancreatic Surgery
; : 262-266, 2010.
Article
em En
| WPRIM
| ID: wpr-109734
Biblioteca responsável:
WPRO
ABSTRACT
A 65-year old man underwent wedge resection for a gastrointestinal stromal tumor (GIST) of the gastric fundus in 1997. In 2003, the abdominal CT and sono-guided biopsy revealed he had a large GIST liver metastasis. He underwent treatment with 400 mg/day of imatinib mesylate. As a result, the liver metastasis markedly decreased in size. However, focal progression of the liver metastasis was observed on the follow up CT, so we increased the imatinib from 400 mg/day to 800 mg/day. We then performed extended left hepatectomy. We report here on a patient who presented with an isolated metastatic GIST to the liver, and the patient was successfully treated with imatinib therapy and hemihepatectomy.
Palavras-chave
Texto completo:
1
Base de dados:
WPRIM
Assunto principal:
Piperazinas
/
Pirimidinas
/
Pirróis
/
Benzamidas
/
Biópsia
/
Seguimentos
/
Mesilatos
/
Tumores do Estroma Gastrointestinal
/
Mesilato de Imatinib
/
Fundo Gástrico
Tipo de estudo:
Observational_studies
/
Prognostic_studies
Limite:
Humans
Idioma:
En
Revista:
Korean Journal of Hepato-Biliary-Pancreatic Surgery
Ano de publicação:
2010
Tipo de documento:
Article